2026-02-19 / Oral Question: State Pharmaceuticals Manufacturing Corporation Drug Varieties (Q. 3/2026)
Hon. Rohana Bandara
2026-02-19
## Summary Hon. Rohana Bandara poses a written question to the Minister of Health and Mass Media regarding the operational and financial performance of the State Pharmaceuticals Manufacturing Corporation (SPMC). The question requests a year-by-year breakdown (2020 to present) of drug varieties manufactured by the SPMC, including specific details on any medicines sold to private traders below production cost, the resulting financial losses incurred by the Corporation, and what remedial measures are planned. The question implicitly raises concerns about potential mismanagement or below-cost pricing practices at the state-owned pharmaceutical manufacturer.
Question to the Minister of Health and Mass Media:
(a) Will he inform this House:
(i) the number of varieties of medicinal drugs manufactured by the State Pharmaceuticals Manufacturing Corporation (SPMC) in each year from 2020 to date and the names of such drugs, separately;
(ii) those medicinal drugs, and their quantities, sold to private traders at prices lower than production cost;
(iii) the loss incurred by the Corporation due to such sales; and
(iv) the measures to be taken in this regard?
(b) If not, why?